Rhod Harries
Analyst · Citi Research. You may proceed
Thank you, Sophie and good afternoon to all and thank you for joining the call. We hope everyone is staying safe and keeping as well as possible during this unprecedented time. Before we get to the results for the quarter, let’s start with an update on the COVID-19 related actions the company has taken since March 23 when we last talked with you. From the outset as the whole situation that developed, our first priority has been and remains the health and welfare of our employees, customers, suppliers and other partners as we ensure the continuity of our business. In this regard, we are very pleased that our production of face masks and isolation gowns is now underway. We are currently selling masks in some of our facilities in Central America to support local government requirements as well as on behalf of a cooperative consortium of North American apparel and textile companies supplying non-medical masks to the healthcare sector. We are also producing non-medical masks and isolation gowns for various retailers to be distributed to healthcare organizations. In total, we have current plans to produce over 150 million masks and gowns under this effort and we will continue to provide as much supply of product as we can as we move through the pandemic. In order to support production of masks and gowns, we have limited manufacturing activity currently underway operating with stringent safety processes and protocols in place. Far and away the majority of our manufacturing capacity around the world remains idle after we extend the shutdown of our operations following mid-April to respective government directives and to manage our inventory levels given the significant downturn in demand caused by the pandemic. Our distribution centers which have strong inventory levels mostly remain open to service customers with appropriate safety measures in place for our employees, but at much reduced operating levels. In parallel with its reduced operating activity, we have moved quickly and decisively to control all costs for non-critical capital investments and to manage our working capital. In this regard, on March 30, we implemented a number of workforce measures. The Gildan Board of Directors, Glenn, myself, and the rest of the executive team agreed to forego 50% of our salaries and we have implemented pay reductions ranging from 20% to 35% across all senior management levels. Further, much of our salaried workforce is now operating on a 4-day workweek. Finally, given the uncertain duration of this price and the related economic impacts, we have moved forward with major additional actions to strengthen our balance sheet and liquidity position. In our March update, we indicated that after drawing down the remaining available portion of our revolving long-term bank credit facility, we stood with just over $500 million of cash and over $50 million of available credit lines. On April 6, we secured an additional $400 million of long-term debt providing us with liquidity of over $950 million and we are currently operating with just over $650 million of cash on hand and $300 million of available credit lines. Further, in addition to suspending our share repurchases which we did in early March, today, we announced that we will be suspending our quarterly dividend starting with the first quarter. While returning capital to shareholders is a key priority for Gildan and we remain fully committed to doing so when the environment normalizes, we have taken these actions to ensure that we are extremely well positioned to move through this evolving, challenging and highly uncertain environment. Now, moving on to our first quarter results, we generated $459 million in sales, down 26.4% over the prior year quarter mainly due to lower sales volumes. Although our initial expectations called for lower volumes in the first quarter, the overall volume declines in the quarter were meaningfully higher than we anticipated given significantly weaker demand in March. During the first two months of the quarter, our sales performance in North America for imprintables was relatively on track, but fell off considerably in March typically the biggest sales month on the first quarter as the spread of the pandemic started to heighten in North America. Further, our retail sales were also impacted although less severely in the mass and online channels. Overall, these year-over-year volume declines in the quarter were partly offset by positive product mix and slightly higher net selling prices due to lower discounting. Activewear sales of approximately $373 million fell 24.5% during the quarter driven in imprintables by double-digit unit volume declines in both North America and international as well as due to a $6 million sales return allowance related to our SKU rationalization initiative. In retail, activewear sales were down due to store closures and lower demand caused by the pandemic although the decline was less severe than we saw in imprintables. In the hosiery and underwear category, we generated $86.5 million in sales in the first quarter, down 34% compared to last quarter as the downturn in demand related to store closures drove lower sales. In addition, as we highlighted in February when we reported our 2019 first quarter results, the decline in hosiery this quarter also reflected the impact from the exit of a stock program in masks and the year-over-year impact of the initial rollout of a new private brand sock program which launched in the first quarter last year. In underwear, overall sales were down due to the current challenging demand environment and the year-over-year impact of fully exiting a branded underwear program in masks at the end of the first quarter of 2019 partly offset by increased sales of private brand men’s underwear in the mass channel. Gross margin in the first quarter was 23.2% and adjusted gross margin was 24.6%, after excluding an $8 million charge related to discontinued imprintable SKUs. Although adjusted gross margin was down 120 basis points over the first quarter of 2019, it is important to highlight that the year-over-year variance included 340 basis points of negative variance related to manufacturing idling and other COVID-19 related costs. Without these costs, adjusted gross margin would have been 28%, 220 basis points above the prior year level. Accordingly, COVID-19 costs more than offset favorable product mix related to our underwear business, lower raw material cost and most notably, the benefit of an improving cost structure from manufacturing optimization issues under our back-to-basic strategy. Moving to SG&A expenses, for the first quarter, SG&A expenses totaled $74 million, down $19 million over last year primarily resulting from reductions in compensation expenses, lower volume-driven distribution expenses and from tightly managing all our costs, including eliminating all discretionary expenses as we move through the back part of the quarter. Now, let me highlight certain impairment charges taken in the quarter in light of the impact of the COVID-19 situation. During the first quarter, although we did not incur any significant customer-specific accounts receivable write-offs, we increased our allowance for expected credit losses to reflect heightened credit risk in this environment. As you would expect, some of our customers are working to navigate through this challenging period and have requested extended payment terms on their account balances as they closely manage their operations and working capital positions. While we are working with these customers and fully expect payment, we are nonetheless less required to assign an element of risk to these receivables and adjust our allowance for credit losses accordingly. In addition, this quarter we have recorded an impairment charge of $94 million relating to goodwill and intangible assets acquired in previous sock and hosiery business acquisitions after conducting an impairment review of our hosiery cash generating unit. While our longer term outlook for this business – for this part of our business remains unchanged and we believe that we are well positioned from a competitor perspective, the impairment was triggered by the broad impact of COVID-19 on market valuations, including for Gildan. Finally, in the first quarter, we recorded $10 million of anticipated restructuring and acquisition related costs largely associated with the relocation of our Mexican operations and costs related to the completion of the exit of our shifted apiece activities. Adding up all these elements, our operating loss in the quarter totaled $92 million compared to operating income of $33 million in the prior year. Before reflecting charges associated with restructuring and acquisition related costs, the goodwill and intangible asset impairment and discontinued imprintable SKUs, we generated adjusted operating income of $20 million in the quarter compared to $43 million in 2019. And net loss for the quarter was $0.50 per share, while adjusted EPS was $0.06, down from $0.16 last year, reflecting the sales and operating margin decline, including $0.08 of manufacturing idling and COVID related costs. Turning to free cash flow, we consumed $235 million of free cash flow in the first quarter of 2020 compared to $128 million consumed last year for this period. The change was mainly due to the decrease in earnings in the quarter and higher working capital from increased finished goods inventory due to a planned inventory build in the first part of the quarter. Our capital expenditures in the first quarter were approximately $26 million, primarily for textile and yarn operations. We expect lower levels of capital spending going forward as we defer non-clinical capital expenditures in the near-term. Finally, under our 2019 share repurchase program, we bought back just over 843,000 shares in the first two months of 2020 for a total cost of $23.2 million. At quarter end, we had net debt of just over $1.1 billion and a net debt leverage ratio of 2.2x trailing 12 months adjusted EBITDA. Now, a few words on the outlook. Visibility regarding the duration and extent of the impact of the pandemic remains extremely low. And as you are already aware on March 23, we withdrew our quarterly and annual guidance. However, to provide further context, we thought it would be helpful to update you on the demand trends we have seen thus far in April. In the imprintables channel, when we last talked during the third week of March, POS was down approximately 50% and we expected further weakness. Guests played out of the end of March and in April we have seen POS trending down 75% versus prior year levels. Turning to our international imprintables channels, POS in Europe is tracking at similar levels as North America, while Asia is slightly better with POS down 65% from last year’s levels. POS in retail channels has also decelerated in April as more and more retailers closed their doors in response to shelter-in-place and non-essential business closure directives. Overall, POS in the retail channel is down 45% in April. In this regard, our branded and licensed sock business and our global lifestyle private brand business has experienced weaker levels of POS given our high exposure to the apartment, sporting and specialty store channels as well as large sporting-related events. On the other hand, we are very encouraged by the strong performance of our private brand underwear business in mass stores and our e-commerce sales. Particularly as online retailers are starting to include our basic apparel product categories as priority shipments along with essentials. At this juncture, it is unclear how these trends will evolve as different actions are enacted in various jurisdictions to adjust to the ongoing phases of the pandemic. However, given what we have seen thus far in April and given broader economic expectations, we do expect a significant decline in POS and shipments for the second quarter of 2020. Accordingly, this sales outlook, combined with the impact of fixed cost absorption, while our manufacturing facilities remain idle, will likely lead to a significant earnings loss in the second quarter of 2020. In closing, despite this outlook, the actions we have taken positions Gildan well to navigate through this challenging environment. As I highlighted earlier, our primary focus is the health and well-being of our people and the continuity and long-term success of the business. We are very proud as how our whole organization has adapted to deal with the current environment, including responding to the help alleviate global PPE shortages. We have taken the steps to reduce our fixed costs and expect to continue to lower our expenses as we move forward and adjust to a weak demand outlook, which could extend through the remainder of the year. We have good inventory levels in all product categories to service our customers and we have strong liquidity overall. Further our back-to-basic strategy, which we have been implementing over the last 2 years to simplify and lower our cost structure has put us in a better position to deal with these events. We have successfully navigated through challenging environments in the past and we are confident that our strong business model, financial position and resilience will allow us to emerge successfully from this global crisis, positioned well for the long-term. With that, thank you and I will turn the call back over to Sophie.